Th17 cells are recruited to tumor sites and inflammatory sites by C-C motif chemokine ligand 20 (CCL20) expressed by epithelial and stromal cells, interacting with C-C Chemokine receptor type 6 (CCR6) on Th17 cells (5, 6). The gene discussed is CCR6; the disease is neoplasm.